Benzinga | Nov 5, 2020 05:08PM EST

BioLife Solutions Q3 EPS $(0.02), Inline, Sales $11.28M Beat $10.82M Estimate

BioLife Solutions (NASDAQ:BLFS) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 300 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $11.28 million which beat the analyst consensus estimate of $10.82 million by 4.24 percent. This is a 70.79 percent increase over sales of $6.60 million the same period last year.